OncoStem Diagnostics
-
Zydus Lifesciences bags exclusively marketing rights for breast cancer test
CanAssist Breast is an innovative prognostic test for breast cancer patients Zydus Lifesciences announced that it will be exclusively marketing…
Read More » -
OncoStem Diagnostics wins Aegis Graham Bell Award
OncoStem was recognised for its innovative AI-based prognostic test ‘CanAssist Breast’ OncoStem Diagnostics, an oncology focussed company that enables personalised cancer…
Read More »